
CASE STUDY| Cancer-killing bacteria
Ralph, a 57-year-old man, was diagnosed with colon cancer. His oncologist discussed the use of radiation and chemotherapy as treatments for this cancer and explained that each of these therapies kills actively dividing normal and cancer cells, causing debilitating side effects. Ralph decided to carefully review his options and went for a second opinion to a cancer clinic at a major teaching hospital. There he learned that researchers in a synthetic biology program were testing the use of genetically modified E. coli that selectively invade and kill cancer cells, with no effects on normal cells. Ralph decided to participate in this trial, and at an appointment to learn about the details, he was informed that he would be part of a Phase III trial, comparing the effectsof the modified bacterial cells against conventional chemotherapy. As part of the trial, he would be randomly assigned to receive one or the other treatment. He was disappointed to learn this, because he assumed that he would receive the bacterial therapy.
What are Ralph's options at this point?

Case summary:
A 57-year-old man, Ralph, has colon cancer. Ralph came to know that chemotherapy and radiation treatments for the cancer are responsible for killing the cancerous cells along with the normal dividing cell and cause side effects. His oncologist advised him to go for synthetic biology program, in which the researchers use the genetically modified organism for the treatment of cancer patients.
Characters in the case:
A 57-year-old-man, Ralph.
Adequate information:
Ralph has colon cancer and decided to go for the synthetic biology program for the treatment of cancer. Researchers of this program use genetically modified Escherichia coli that selectively kill the cancer cells. He would be a part of a trial for this program and would receive the random treatment of bacterial therapy.
To determine:
Ralph’s options for cancer treatment after knowing that he would be getting random treatments for bacterial therapy.
Explanation of Solution
Given information:
Ralph is selected for the phase III trial, in which random treatments would be given for the treatment of cancer, which may be the modified bacterial therapy or the other therapies.
Cancer is a life-threatening disease, in which normal cells start dividing abnormally. These cells have the potential to invade other parts of the body. It results in the formation of the tumor and the cells inside the tumor grow in an unregulated manner. Cancer arises when normal cells lose the ability of contact inhibition and cells lack the programmed cell death mechanism.
All the cancerous cells acquire the property of metastasis. Colon cancer refers to the abnormal growth of the cells of the colon located at the lower end of the digestive tract. For the treatment of cancers, several chemotherapy treatments and radiations therapy have been used. These therapies have proved beneficial in many cases but they have a variety of side effects on the body and also kill normal cells along with the cancerous cells.
Advancement in the synthetic biology techniques led to the use of synthetic biology and application of synthetic genome for the treatment of various diseases such as cancer. Synthetic biology programmes result in the formation of genetically modified organisms (GMOs) that kill the selective cells responsible for the disease. These treatments have been proved very successful in many cases and have lesser side effects on the body as compared to the conventional chemotherapy and radiation treatments.
In this case, Ralph was disappointed because he was not able to get all the required treatments for the effective cure of his disease. Ralph was assuming that he would get the bacterial therapy. He should think that by knowing the synthetic biology programme for the cancer treatment, he came to know about the more options for the treatments apart from the conventional treatments and can opt such options when needed.
Thus, it can be concluded that Ralph would know more options for the cancer treatments beside the chemotherapy. He could have knowledge of the specific type of therapies having lesser side effects by joining the synthetic biology programme.
Want to see more full solutions like this?
Chapter 19 Solutions
Essentials of Genetics (9th Edition) - Standalone book
- If a bacterium using aerobic respiration was to degrade one small protein molecule into 8 molecules of pyruvic acid, how many ATP would that cell make? Assume there is no other carbon source. Units cannot be entered in this style of question but the units of your answer should be in molecules of ATP.arrow_forwardIf a bacterium using aerobic respiration was to degrade a 30 mM solution of citric acid, how many ATP would that cell make? Assume no other carbon source is available. Units cannot be entered in this style of question but the units of your answer should be in mM of ATP.arrow_forwardHow much ATP will be produced during the following metabolic scenario: Aerobic respiration of a 5mM lipid solution that is made up of one glycerol and an 8-carbon fatty acid and 12-carbon fatty acid. Recall that when glycerol breaks down to Glyceraldehyde-3-phosphate it costs one ATP but your get an extra FADH2. Every two carbons of a fatty acid break down to one acetyl-CoA. (pathways will be provided on the exam) Units cannot be entered in this style of question but the units of your answer should be in mM of ATP.arrow_forward
- When beta-lactamase was isolated from Staphylcoccus aureus and treated with a phosphorylating agent, only the active site, serine was phosphorylated. Additionally, the serine was found to constitute 0.35% (by weight) of this beta-lactamase enzyme. Using this, calculate the molecular weight of this enzyme and estimate the number of amino acids present in the polypeptide.arrow_forwardBased on your results from the Mannitol Salt Agar (MSA) media, which of your bacteria were mannitol fermenters and which were not mannitol fermenters?arrow_forwardhelp tutor pleasearrow_forward
- Q8. A researcher wants to study the effectiveness of a pill intended to reduce stomach heartburn in pregnant women. The researcher chooses randomly 400 women to participate in this experiment for 9 months of their pregnancy period. They all need to have the same diet. The researcher designs two groups of 200 participants: One group take the real medication intended to reduce heartburn, while the other group take placebo medication. In this study what are: Independent variable: Dependent variable: Control variable: Experimental group: " Control group: If the participants do not know who is consuming the real pills and who is consuming the sugar pills. This study is It happens that 40% of the participants do not find the treatment helpful and drop out after 6 months. The researcher throws out the data from subjects that drop out. What type of bias is there in this study? If the company who makes the medication funds this research, what type of bias might exist in this research work?arrow_forwardHow do I determine the inhertiance pattern from the pedigree diagram?arrow_forwardits an open book assignemntarrow_forward
- Describe two different gene regulation mechanisms involving methylationarrow_forwardWhat is behavioral adaptarrow_forward22. Which of the following mutant proteins is expected to have a dominant negative effect when over- expressed in normal cells? a. mutant PI3-kinase that lacks the SH2 domain but retains the kinase function b. mutant Grb2 protein that cannot bind to RTK c. mutant RTK that lacks the extracellular domain d. mutant PDK that has the PH domain but lost the kinase function e. all of the abovearrow_forward
- Human Heredity: Principles and Issues (MindTap Co...BiologyISBN:9781305251052Author:Michael CummingsPublisher:Cengage LearningBiology: The Dynamic Science (MindTap Course List)BiologyISBN:9781305389892Author:Peter J. Russell, Paul E. Hertz, Beverly McMillanPublisher:Cengage LearningBiology 2eBiologyISBN:9781947172517Author:Matthew Douglas, Jung Choi, Mary Ann ClarkPublisher:OpenStax
- Biology Today and Tomorrow without Physiology (Mi...BiologyISBN:9781305117396Author:Cecie Starr, Christine Evers, Lisa StarrPublisher:Cengage LearningBiology (MindTap Course List)BiologyISBN:9781337392938Author:Eldra Solomon, Charles Martin, Diana W. Martin, Linda R. BergPublisher:Cengage Learning




